OV-632 AND MOC-31 IN THE DIAGNOSIS OF MESOTHELIOMA AND ADENOCARCINOMA - AN ASSESSMENT OF THEIR USE IN FORMALIN-FIXED AND PARAFFIN WAX EMBEDDED MATERIAL

被引:44
作者
EDWARDS, C
OATES, J
机构
[1] Department of Histopathology, Birmingham Heartlands Hospital, Birmingham B9 5SS, Bordesley Green East
关键词
OV; 632; MOC; 31; ADENOCARCINOMA; MESOTHELIOMA;
D O I
10.1136/jcp.48.7.626
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Aims-To investigate the reaction of antibodies OV 632 and MOC 31 in paraffin wax sections as opposed to frozen sections and cytological preparations; to evaluate their usefulness in the differential diagnosis of malignant mesothelioma and secondary adenocarcinoma of the pleura; and to assess the efficacy of microwave pretreatment of sections in unmasking their associated epitopes. Methods-Immunohistochemistry, using a standard avidin-biotin technique, with microwave pretreatment and trypsinisation in a certain proportion of cases. The material comprised 43 mesotheliomas, 44 adenocarcinomas and five reactive pleuras. Results-Epithelial mesotheliomas and the hyperplastic mesothelial cells reacted strongly with OV 632, the reaction with sarcomatoid and desmoplastic tumours was weak, and the reaction with adenocarcinomas was variable. An unequivocal but sometimes patchy positive reaction was obtained with MOC 31 in all but one of the adenocarcinomas; all but one of the mesotheliomas and all the reactive pleuras were negative. Review of the two apparently anomalous cases revealed that the original diagnoses had probably been incorrect. Reactions to both antibodies were abolished by microwave pretreatment, and also by prior trypsinisation in the case of OV 632. Conclusions-OV 632 is unsuitable for routine clinical use in paraffin wax embedded material. MOC 31, however, would be a useful addition to a panel of antibodies in the differential diagnosis of mesothelioma and adenocarcinoma in large biopsy and resection specimens and necropsy material. its value in small biopsy specimens remains to be assessed. Microwave pretreatment does not enhance the reactions with either antibody.
引用
收藏
页码:626 / 630
页数:5
相关论文
共 16 条
  • [1] PLEURAL MALIGNANT MESOTHELIOMA FOLLOWING WILMS-TUMOR
    AUSTIN, MB
    FECHNER, RE
    ROGGLI, VL
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1986, 86 (02) : 227 - 230
  • [2] MULTIPLE-MARKER IMMUNOHISTOCHEMICAL PHENOTYPES DISTINGUISHING MALIGNANT PLEURAL MESOTHELIOMA FROM PULMONARY ADENOCARCINOMA
    BROWN, RW
    CLARK, GM
    TANDON, AK
    ALLRED, DC
    [J]. HUMAN PATHOLOGY, 1993, 24 (04) : 347 - 354
  • [3] MICROWAVE ANTIGEN RETRIEVAL IN IMMUNOCYTOCHEMISTRY - A STUDY OF 80 ANTIBODIES
    CUEVAS, EC
    BATEMAN, AC
    WILKINS, BS
    JOHNSON, PA
    WILLIAMS, JH
    LEE, AHS
    JONES, DB
    WRIGHT, DH
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 1994, 47 (05) : 448 - 452
  • [4] IMMUNOCYTOCHEMISTRY OF MALIGNANT MESOTHELIOMA - OV632 AS A MARKER OF MALIGNANT MESOTHELIOMA
    DELAHAYE, M
    HOOGSTEDEN, HC
    VANDERKWAST, TH
    [J]. JOURNAL OF PATHOLOGY, 1991, 165 (02) : 137 - 143
  • [5] FLEUREN GJ, 1987, VIRCHOWS ARCH A, V410, P481
  • [6] FRISMAN DM, 1993, MODERN PATHOL, V6, P179
  • [7] Henderson DS, 1992, MALIGNANT MESOTHELIO, P69
  • [8] KOSS M, 1992, SEMIN DIAGN PATHOL, V9, P117
  • [9] ROGGLI VL, 1987, PATHOL ANNU, V22, P91
  • [10] RUITENBEEK T, 1994, ARCH PATHOL LAB MED, V118, P265